Metagenomi Therapeutics (MGX) Other Non-Current Assets (2023 - 2026)
Metagenomi Therapeutics (MGX) reported Other Non-Current Assets of $4.4 million for Q1 2026, down 16.29% year-over-year from $5.2 million in Q1 2025, and up 425.48% quarter-over-quarter from $836000.0 in Q4 2025.
Metagenomi Therapeutics (MGX) Other Non-Current Assets (2023 - 2026) Analysis & Trends
Metagenomi Therapeutics (MGX) has 4 years of Other Non-Current Assets data on file, last reported at $4.4 million in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $4.4 million, down 16.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.4 million (down 16.29% YoY), and the FY2025 annual result was $836000.0, down 84.07% from the prior year.
- Other Non-Current Assets grew to $4.4 million in Q1 2026 per MGX's latest filing, from $836000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $6.1 million in Q1 2023 and troughed at $836000.0 in Q4 2025.
- A 4-year average of $4.9 million and a median of $5.2 million in 2023 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets changed 0.0% in 2024, then tumbled 84.07% in 2025.
- A 4-year view of Other Non-Current Assets shows it stood at $5.2 million in 2023, then changed by 0.0% to $5.2 million in 2024, then plunged by 84.07% to $836000.0 in 2025, then soared by 425.48% to $4.4 million in 2026.
- Business Quant data shows MGX's Other Non-Current Assets at $4.4 million in Q1 2026, $836000.0 in Q4 2025, and $5.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - | - |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - | - |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - | - |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - | - |
| 10 | Metagenomi Therapeutics | 42.84 Mn | 42.84 Mn | - | 4.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.39 Mn |
| Dec 31, 2025 | 836,000.00 |
| Sep 30, 2025 | 5.25 Mn |
| Jun 30, 2025 | 5.25 Mn |
| Mar 31, 2025 | 5.25 Mn |
| Dec 31, 2024 | 5.25 Mn |
| Sep 30, 2024 | 5.25 Mn |
| Jun 30, 2024 | 5.25 Mn |
| Mar 31, 2024 | 5.25 Mn |
| Dec 31, 2023 | 5.25 Mn |
| Sep 30, 2023 | 5.25 Mn |
| Jun 30, 2023 | 5.25 Mn |
| Mar 31, 2023 | 6.07 Mn |